| Name | Title | Contact Details |
|---|
Aegis Sciences Corporation is a toxicology laboratory specializing in forensic and healthcare services that provides science-driven testing and consulting for clients, such as professional and amateur sports organizations, distinguished college and university athletic programs, healthcare professionals, Fortune 500 companies, medical examiners, and government agencies throughout the United States. Aegis developed and has specialized in Zero Tolerance Drug Testing® services to ensure workplaces and sports programs are truly drug free. Since its inception as a sports anti-doping lab at Vanderbilt University, Aegis has helped keep athletes clean and in the game.
Torealis Research Inc. is a Aurora, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Oral Arts Dental Laboratory is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Casie Protank is a Vineland, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics` extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation.